Step 1 topics → Respiratory → High-Altitude Physiology

High-Altitude Physiology

USMLE Step 1 trap: Incorrectly labels altitude-induced hyperventilation as causing respiratory acidosis. Hyperventilation at altitude causes respiratory alkalosis by lowering PaCO2; this is the acute response to hypoxic stimulation of peripheral chemoreceptors.

High-altitude physiology covers what happens when you drop ambient PO2 and the body has to compensate — acutely through ventilation and acid-base shifts, chronically through hematologic and vascular remodeling. USMLE Step 1 tests this in two main ways: mechanistic questions about the acid-base response (what changes, what compensates, in what order), and clinical questions about altitude illness syndromes and their treatments. The topic is 'low HY tier' but it's a reliable source of one or two questions per exam because the concepts are clean and well-defined.

The trickiest part is keeping the timeline straight. The acute response is driven by hypoxia stimulating peripheral chemoreceptors (carotid bodies), triggering hyperventilation, which drops PaCO2 and causes respiratory alkalosis — not acidosis. Many students flip this. The kidneys then compensate over days by excreting bicarbonate, shifting the pH back toward normal (metabolic compensation). Chronic adaptation adds EPO-mediated erythrocytosis, rightward shift of the O2-hemoglobin dissociation curve (2,3-BPG), and pulmonary vasoconstriction. These all layer on top of each other.

Acetazolamide is the classic pharmacology hook here. Students often assume it works by doing something to oxygen directly, but it doesn't touch O2 — it forces bicarbonate wasting through carbonic anhydrase inhibition, creating a mild metabolic acidosis that pushes ventilation harder and accelerates the acclimatization process. USMLE Step 1 loves this mechanism because it ties renal physiology, acid-base, and respiratory physiology into one drug.

From real student decks
22%have cards covering this topic
3%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: The hyperventilation at high altitude causes respiratory acidosis because CO2 is being blown off.
Right: Hyperventilation at altitude causes respiratory alkalosis by lowering PaCO2; this is the acute response to hypoxic stimulation of peripheral chemoreceptors.
Hyperventilation means you're blowing off CO2, which lowers PaCO2 — and lower PaCO2 means higher pH, which is alkalosis, not acidosis. Think of it this way: CO2 is an acid in solution (CO2 + H2O → H2CO3), so losing CO2 makes the blood more basic. The confusion usually comes from mixing up 'CO2 is being lost' with 'acid is being produced' — they're the opposite effect on pH.
Common mistake
Wrong: Acetazolamide treats altitude sickness by increasing O2 delivery directly.
Right: Acetazolamide inhibits carbonic anhydrase in the kidney, causing bicarbonate diuresis and metabolic acidosis that stimulates ventilation, accelerating acclimatization.
Acetazolamide has no direct effect on oxygen — it doesn't increase O2 delivery, doesn't shift the hemoglobin curve, and doesn't affect the lungs. Its entire benefit is renal: by blocking carbonic anhydrase in the proximal tubule, it prevents bicarbonate reabsorption, causing bicarb wasting in the urine. This intentional metabolic acidosis counteracts the respiratory alkalosis of hyperventilation, which removes the blunting effect on the peripheral chemoreceptors and allows ventilation to increase further — speeding up acclimatization.
Common mistake
Gap: Missing EPO-driven erythrocytosis as the key chronic hematologic adaptation to altitude
Chronic altitude exposure triggers EPO release from the kidney in response to hypoxia, increasing RBC mass and hemoglobin concentration to improve O2-carrying capacity.
When tissue PO2 drops chronically, peritubular cells in the kidney sense hypoxia and upregulate HIF-1α, which drives EPO transcription. EPO acts on bone marrow to expand the erythroid lineage, increasing RBC mass and total hemoglobin — the key mechanism for improving O2-carrying capacity over weeks at altitude. This is the same EPO pathway that gets abused in blood doping, and it's the same pathway that goes wrong in renal failure (where EPO production drops). Knowing this connection makes it stick.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand the acute ventilatory and acid-base response to altitude: hypoxia → peripheral chemoreceptor activation → hyperventilation → decreased PaCO2 → respiratory alkalosis, followed by renal bicarbonate excretion as metabolic compensation over days.
  2. Understand the chronic adaptations to altitude: EPO release from the kidney in response to hypoxia drives erythrocytosis and increased hemoglobin mass; 2,3-BPG rises to shift the O2-Hgb curve rightward; pulmonary vasoconstriction redistributes blood flow.
  3. Recognize AMS, HAPE, and HACE by their clinical features and know the treatment rationale: descent is definitive, supplemental O2 helps, and acetazolamide accelerates acclimatization by inducing renal bicarbonate wasting (not by directly increasing O2 delivery).

Can you avoid these mistakes?

A climber ascends rapidly to 4,000 meters. His arterial blood gas shows pH 7.48, PaCO2 28, HCO3 20. What is the primary acid-base disturbance, and what drove it?
Three days later, the same climber's kidneys have fully compensated. Describe the expected direction of change in serum bicarbonate and explain the mechanism. What does this compensation do to the stimulus for ventilation?
A trekker develops severe headache, confusion, and ataxia at high altitude. What is the diagnosis, and what is the immediate priority in management?
A physician prescribes acetazolamide prophylactically before a trip to altitude. The patient asks how it works. Which of the following best explains the mechanism: (A) increases O2 binding to hemoglobin, (B) stimulates EPO release, (C) causes renal bicarbonate wasting leading to metabolic acidosis that stimulates ventilation, or (D) blocks pulmonary vasoconstriction?

Related topics

Five Causes of Hypoxemia Lung Development Stages Surfactant Production and Neonatal RDS Bronchopulmonary Dysplasia Congenital Diaphragmatic Hernia

See how your Anki deck covers this topic.

Upload your deck for a free audit →